David Palma
Clinical trials sponsored by David Palma, explained in plain language.
-
Could 5 radiation sessions be as good as 30 for skin cancer?
Disease control Recruiting nowThis study tests whether a shorter, more intense type of radiation (stereotactic radiotherapy given in 5 sessions) works as well as the standard longer course (20-30 sessions) for treating skin cancer that has spread to the parotid gland in the head and neck. About 90 adults who …
Phase: NA • Sponsor: David Palma • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New trial: can targeted radiation boost survival in patients with up to 10 metastases?
Disease control Recruiting nowThis phase III trial tests whether adding stereotactic ablative radiotherapy (SABR) to standard treatment (chemotherapy, hormone therapy, or palliative radiation) improves survival in adults with 1 to 10 metastatic tumors and an active primary cancer. About 180 participants will …
Phase: PHASE3 • Sponsor: David Palma • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Simple drugs may ease radiation breathing woes for lung patients
Symptom relief Recruiting nowThis study tests whether N-acetyl cysteine (NAC) and a short course of steroids can reduce severe shortness of breath after lung radiation in people with both lung cancer and interstitial lung disease. About 98 participants will receive either NAC or placebo, plus either steroids…
Phase: PHASE2 • Sponsor: David Palma • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC